ROLE OF BRAIN NORADRENALINE IN THE REGULATION OF PITUITARY-ADRENOCORTICAL FUNCTIONS

in Journal of Endocrinology
Authors:
H. KUMEDA
Search for other papers by H. KUMEDA in
Current site
Google Scholar
PubMed
Close
,
H. UCHIMURA
Search for other papers by H. UCHIMURA in
Current site
Google Scholar
PubMed
Close
,
T. KAWABATA
Search for other papers by T. KAWABATA in
Current site
Google Scholar
PubMed
Close
,
Y. MAEDA
Search for other papers by Y. MAEDA in
Current site
Google Scholar
PubMed
Close
,
O. OKAMOTO
Search for other papers by O. OKAMOTO in
Current site
Google Scholar
PubMed
Close
,
A. KAWA
Search for other papers by A. KAWA in
Current site
Google Scholar
PubMed
Close
, and
T. KANEHISA
Search for other papers by T. KANEHISA in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

Although brain amines have been suggested as neurotransmitters regulating the release of hypothalamic hormones, some conflicting evidence has still to be explained. Scapagnini, Van Loon, Moberg & Ganong (1970) have implicated brain noradrenaline in the inhibitory control of adrenocorticotrophin (ACTH) secretion, based on the results of intraperitoneal injection of α-methyl-p-tyrosine. However, we found no increase in corticosterone after oral administration of α-methyl-p-tyrosine to rats (Uchimura, Kumeda, Kawabata, Maeda, Tada, Okamoto, Ogawa & Inamori, 1972).

In this study we have examined the effects of intraventricular administration of 6-hydroxydopamine (6-OHDA), a specific and long-lasting catecholamine depletor which does not cross the blood-brain barrier thus excluding the effects of serotonin, peripheral noradrenaline or peritoneal irritation. We performed the experiments 2 weeks after intraventricular administration of 6-OHDA to avoid the stress effects of the administration of 6-OHDA itself.

Male Wistar rats (125–250 g), caged singly, were used. Each rat was

 

  • Collapse
  • Expand